Literature DB >> 8748394

Effects of oxazepam on event-related brain potentials, EEG frequency bands, and vigilance performance.

T H van Leeuwen1, M N Verbaten, H S Koelega, J L Slangen, J van der Gugten, G Camfferman.   

Abstract

Eighteen males performed two vigilance tasks with static and dynamic stimuli under the influence of oxazepam (20 and 40 mg) in a placebo-controlled, double blind, crossover design. Oxazepam dose-dependently impaired overall level of performance and aggravated the decrement with time in measures of accuracy and sensitivity relative to placebo. The drug reduced the amplitudes of the P1, N1, P2N2, and P3 (dose-dependently) waves of event-related potentials (ERPs). Oxazepam aggravated the linear decline with time of the P3 amplitude only. Oxazepam impaired accuracy was related to deterioration of central processing involved in stimulus discrimination (P2N2). Impairment of response-related performance measures (RT and RI) was associated with processing manifest in the P1, N1, and P3 waves. Oxazepam effects on the amplitudes of N1 and P3 correlated with drug effects on power in alpha 1 (8-10 Hz). Drug effects on overall performance and alpha were also related; the drug effect on response speed correlated only with the drug effect on beta 1 (12.5-21 Hz). Effects of time-on-task on performance and EEG were unrelated, but oxazepam induced performance declines with time may have been caused by declines in resource allocation, as manifest in the amplitude of P3. Time effects on EEG power bands and ERP amplitudes were not significantly related to the time course of oxazepam activity. A curious dissociation emerged: both oxazepam and time-on-task impaired performance, but the drug induced a decrease of theta and alpha 1 power, whereas time-on-task increased power. Various processes play a role in performance decrements with time, and various aspects of processing may be involved in signal-detection measures which makes terms such as sensitivity quite meaningless. So-called computational processing was indistinguishable from energetic processes, which questions the validity of the distinction between these two domains. Explanations of EEG activity in terms of a unidimensional theory of arousal are untenable.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8748394     DOI: 10.1007/bf02246546

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  39 in total

1.  EEG theta activity increase coinciding with performance decrement in a monotonous task.

Authors:  M Horváth; E Frantík; K Kopriva; J Meissner
Journal:  Act Nerv Super (Praha)       Date:  1976

2.  Behavioral, event-related potential, and EEG/FFT changes at sleep onset.

Authors:  R D Ogilvie; I A Simons; R H Kuderian; T MacDonald; J Rustenburg
Journal:  Psychophysiology       Date:  1991-01       Impact factor: 4.016

3.  Auditory stimulus intensity responses and frontal midline theta rhythm.

Authors:  N Bruneau; S Roux; P Guérin; B Garreau; G Lelord
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1993-03

4.  Lapses in alertness: coherence of fluctuations in performance and EEG spectrum.

Authors:  S Makeig; M Inlow
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1993-01

5.  Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo.

Authors:  D J Greenblatt; B L Ehrenberg; J Gunderman; A Locniskar; J M Scavone; J S Harmatz; R I Shader
Journal:  Clin Pharmacol Ther       Date:  1989-04       Impact factor: 6.875

6.  Slow wave and P300 in signal detection.

Authors:  D S Ruchkin; S Sutton; M L Kietzman; K Silver
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1980-10

7.  Periodic appearance of theta rhythm in the frontal midline area during performance of a mental task.

Authors:  Y Mizuki; M Tanaka; H Isozaki; H Nishijima; K Inanaga
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1980-08

8.  Pharmacokinetic and dynamic studies with a new anxiolytic imidazo-pyridine alpidem utilizing pharmaco-EEG and psychometry.

Authors:  B Saletu; J Grünberger; L Linzmayer
Journal:  Int Clin Psychopharmacol       Date:  1986-04       Impact factor: 1.659

9.  The removal of the eye-movement artifact from the EEG by regression analysis in the frequency domain.

Authors:  J C Woestenburg; M N Verbaten; J L Slangen
Journal:  Biol Psychol       Date:  1983 Feb-Mar       Impact factor: 3.251

Review 10.  Benzodiazepines and vigilance performance: a review.

Authors:  H S Koelega
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

View more
  4 in total

Review 1.  How human electrophysiology informs psychopharmacology: from bottom-up driven processing to top-down control.

Authors:  J Leon Kenemans; Seppo Kähkönen
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

2.  Effects of oxazepam on affective perception, recognition, and event-related potentials.

Authors:  Jonas K Olofsson; Katarina Gospic; Predrag Petrovic; Martin Ingvar; Stefan Wiens
Journal:  Psychopharmacology (Berl)       Date:  2011-01-04       Impact factor: 4.530

Review 3.  On the Physiological Modulation and Potential Mechanisms Underlying Parieto-Occipital Alpha Oscillations.

Authors:  Diego Lozano-Soldevilla
Journal:  Front Comput Neurosci       Date:  2018-04-04       Impact factor: 2.380

4.  IPAD: the Integrated Pathway Analysis Database for Systematic Enrichment Analysis.

Authors:  Fan Zhang; Renee Drabier
Journal:  BMC Bioinformatics       Date:  2012-09-11       Impact factor: 3.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.